An interventional study of Cognitive Behavioral Therapy and Cognitive Behavioral therapy with 2 check in calls in Mental Health Issue and Quality of Life, sponsored by Texas Tech University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2026-05-15.
Sponsored by Texas Tech University · Not applicable, Interventional, and Health services research
The overarching goal of this project is to evaluate a current evidence-based practice, Cognitive Behavioral Therapy, for mental health conditions against Cognitive Behavioral Therapy plus two check-in calls a week for adults living in rural Texas.
This two-armed study, for adults living in rural Texas, aims to evaluate current evidence-based practice, Cognitive Behavioral Therapy, for mental health conditions against Cognitive Behavioral Therapy plus two check-in calls a weel.
Texas Tech University is the lead sponsor of 82 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cognitive Behavior Therapy is an evidence-based practice for mental health conditions and has been shown in numerous studies around the world to be effective.
Behavioral: Cognitive Behavioral Therapy
This arm will provide the same as the first with the addition of twice-weekly check-in calls between sessions.
Behavioral: Cognitive Behavioral therapy with 2 check in calls
Individual tele-therapy 12-16 weeks
Cognitive Behavioral therapy with 2 calls a week
Pre-death grief (PG-12)
PG-12 is a questionnaire used to assess grief experiences before the death of a person will a life limiting illness. It is designed for caregivers of individuals with life limiting illnesses, including those with cancer or dementia. The PG-12 helps identify individuals at risk for prolonged grief disorder (PGD) and can be used in conjunction with other assessments.
Time frame: Baseline Weekly before the intervention 1 Month following the intervention 3 Months following the intervention 6 months following the intervention
Started Mar 2023 (actual). Primary completion is estimated for Dec 2028, 68 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Texas Tech University